Market Overview

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)

90.22 -0.17 (-0.19%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2020
After-Hours
EPS:
REV:
0.49
24.808M



Q2 2020
Pre-Market
EPS:
REV:




Q1 2020
After-Hours
EPS:
REV:
1.16
43.484M



Q4 2019
After-Hours
EPS:
REV:
1.7
59.59M



Q3 2019
After-Hours
EPS:
REV:
1.32
45.663M
0.61
22.36M
0.49
24.808M
-19.67%
10.95%
Q2 2019
Pre-Market
EPS:
REV:
2.59
90.043M
0.55
21.01M
0.68
24.987M
23.64%
18.93%
Q1 2019
After-Hours
EPS:
REV:
1.55
56.157M
1.02
39.79M
1.16
43.484M
13.73%
9.28%
Q4 2018
After-Hours
EPS:
REV:
1.31
50.464M
1.18
51.26M
1.7
59.59M
44.07%
16.25%
Q3 2018
Pre-Market
EPS:
REV:
0.69
33.375M
1.03
41.82M
1.32
45.663M
28.16%
9.19%
Q2 2018
After-Hours
EPS:
REV:
0.67
27.995M
2.34
82.2M
2.59
90.043M
10.68%
9.54%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!